Security
Acrivon Therapeutics Inc. · COMMON STOCK
4 owners 3 exits max 0.0% (Vanguard Group Inc.)
owners
4
max %
0.0%
tracked value
$5M
qoq
A 3
E 3
holders
sorted by % of portfolio · long equity only · exits show last held size
| manager | % port | activity | shares | value | history |
|---|---|---|---|---|---|
| Vanguard Group Inc. 2025 Q4 | 0.0% | Add 0.00 pp | 698,857 | $2M | hist |
| Two Sigma Investments, LP 2025 Q4 | 0.0% | Exit 0.00 pp | 585,069 | $1M | hist |
| Renaissance Technologies LLC 2026 Q1 stale | 0.0% | Add 0.00 pp | 758,440 | $1M | hist |
| Marshall Wace - Marshall Wace, LLP 2026 Q1 stale | 0.0% | Add 0.00 pp | 560,436 | $779 | hist |
| Ken Griffin - Citadel Advisors LLC exited 2026 Q1 last 2025 Q4 | 0.0% | Exit 0.00 pp | 1,641,884 | $4M | hist |
| Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 | 0.0% | Exit 0.00 pp | 121,524 | $293 | hist |
| Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 | 0.0% | Exit 0.00 pp | 10,876 | $26 | hist |
No managers match this filter.
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $129.69M | $181.63M | $120.44M |
| Total non-current assets * | $8.57M | $14.96M | $9.27M |
| Total assets | $138.26M | $196.59M | $129.72M |
| Total current liabilities | $13.3M | $17.21M | $15.66M |
| Total non-current liabilities * | $3.77M | $2.59M | $1.54M |
| Total equity | $121.2M | $176.79M | $112.52M |
ownership over time
filing count by report period · click a bar for that quarter’s holders